164 related articles for article (PubMed ID: 35368919)
1. Antitumor Effects of 10058-F4 and Curcumin in Combination Therapy for Pancreatic Cancer In Vitro and In Vivo.
Jie Z; Jinna Z; Jingjun Z; Pengcheng L; Fang Y; Qinyang C; Taiyu C; Hequn J; Tao R
J Healthc Eng; 2022; 2022():1620802. PubMed ID: 35368919
[TBL] [Abstract][Full Text] [Related]
2. [DLys(6)]-luteinizing hormone releasing hormone-curcumin conjugate inhibits pancreatic cancer cell growth in vitro and in vivo.
Aggarwal S; Ndinguri MW; Solipuram R; Wakamatsu N; Hammer RP; Ingram D; Hansel W
Int J Cancer; 2011 Oct; 129(7):1611-23. PubMed ID: 21484797
[TBL] [Abstract][Full Text] [Related]
3. Enhanced antitumor efficacy by the combination of emodin and gemcitabine against human pancreatic cancer cells via downregulation of the expression of XIAP in vitro and in vivo.
Wang ZH; Chen H; Guo HC; Tong HF; Liu JX; Wei WT; Tan W; Ni ZL; Liu HB; Lin SZ
Int J Oncol; 2011 Nov; 39(5):1123-31. PubMed ID: 21743963
[TBL] [Abstract][Full Text] [Related]
4. Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells.
Hong Z; Wang Z; Zhou B; Wang J; Tong H; Liao Y; Zheng P; Jamshed MB; Zhang Q; Chen H
Int J Oncol; 2020 Mar; 56(3):783-793. PubMed ID: 31922213
[TBL] [Abstract][Full Text] [Related]
5. Curcumin AntiCancer Studies in Pancreatic Cancer.
Bimonte S; Barbieri A; Leongito M; Piccirillo M; Giudice A; Pivonello C; de Angelis C; Granata V; Palaia R; Izzo F
Nutrients; 2016 Jul; 8(7):. PubMed ID: 27438851
[TBL] [Abstract][Full Text] [Related]
6. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.
Kunnumakkara AB; Guha S; Krishnan S; Diagaradjane P; Gelovani J; Aggarwal BB
Cancer Res; 2007 Apr; 67(8):3853-61. PubMed ID: 17440100
[TBL] [Abstract][Full Text] [Related]
7. The effects of curcumin on proliferation, apoptosis, invasion, and NEDD4 expression in pancreatic cancer.
Su J; Zhou X; Yin X; Wang L; Zhao Z; Hou Y; Zheng N; Xia J; Wang Z
Biochem Pharmacol; 2017 Sep; 140():28-40. PubMed ID: 28535906
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of curcumin is involved in down-regulation of YAP/TAZ expression in pancreatic cancer cells.
Zhou X; Su J; Feng S; Wang L; Yin X; Yan J; Wang Z
Oncotarget; 2016 Nov; 7(48):79076-79088. PubMed ID: 27738325
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of c-Myc by 10058-F4 induces growth arrest and chemosensitivity in pancreatic ductal adenocarcinoma.
Zhang M; Fan HY; Li SC
Biomed Pharmacother; 2015 Jul; 73():123-8. PubMed ID: 26211592
[TBL] [Abstract][Full Text] [Related]
10. Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis.
Li L; Braiteh FS; Kurzrock R
Cancer; 2005 Sep; 104(6):1322-31. PubMed ID: 16092118
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin inhibits the proliferation of SW1990 pancreatic cancer cell.
Xu M; Bu LM; Wu K; Lu LG; Wang XP
Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3072-9. PubMed ID: 26367731
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF.
Ali S; Ahmad A; Banerjee S; Padhye S; Dominiak K; Schaffert JM; Wang Z; Philip PA; Sarkar FH
Cancer Res; 2010 May; 70(9):3606-17. PubMed ID: 20388782
[TBL] [Abstract][Full Text] [Related]
13. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
[TBL] [Abstract][Full Text] [Related]
14. Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro.
Liu DL; Bu H; Li H; Chen H; Guo HC; Wang ZH; Tong HF; Ni ZL; Liu HB; Lin SZ
Int J Oncol; 2012 Apr; 40(4):1049-57. PubMed ID: 22159556
[TBL] [Abstract][Full Text] [Related]
15. Kaempferol potentiates the sensitivity of pancreatic cancer cells to erlotinib via inhibition of the PI3K/AKT signaling pathway and epidermal growth factor receptor.
Zhang Z; Guo Y; Chen M; Chen F; Liu B; Shen C
Inflammopharmacology; 2021 Oct; 29(5):1587-1601. PubMed ID: 34322786
[TBL] [Abstract][Full Text] [Related]
16. Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells.
Lev-Ari S; Zinger H; Kazanov D; Yona D; Ben-Yosef R; Starr A; Figer A; Arber N
Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S276-80. PubMed ID: 16507392
[TBL] [Abstract][Full Text] [Related]
17. A novel tricarbonylmethane agent (CMC2.24) reduces human pancreatic tumor growth in mice by targeting Ras.
Mallangada NA; Vargas JM; Thomas S; DiGiovanni MG; Vaeth BM; Nemesure MD; Wang R; LaComb JF; Williams JL; Golub LM; Johnson F; Mackenzie GG
Mol Carcinog; 2018 Sep; 57(9):1130-1143. PubMed ID: 29683208
[TBL] [Abstract][Full Text] [Related]
18. CdSe/ZnS quantum dots induce photodynamic effects and cytotoxicity in pancreatic cancer cells.
He SJ; Cao J; Li YS; Yang JC; Zhou M; Qu CY; Zhang Y; Shen F; Chen Y; Li MM; Xu LM
World J Gastroenterol; 2016 Jun; 22(21):5012-22. PubMed ID: 27275093
[TBL] [Abstract][Full Text] [Related]
19. Curcumin attenuates hyperglycemia-driven EGF-induced invasive and migratory abilities of pancreatic cancer via suppression of the ERK and AKT pathways.
Li W; Wang Z; Xiao X; Han L; Wu Z; Ma Q; Cao L
Oncol Rep; 2019 Jan; 41(1):650-658. PubMed ID: 30542713
[TBL] [Abstract][Full Text] [Related]
20. Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer.
Bisht S; Mizuma M; Feldmann G; Ottenhof NA; Hong SM; Pramanik D; Chenna V; Karikari C; Sharma R; Goggins MG; Rudek MA; Ravi R; Maitra A; Maitra A
Mol Cancer Ther; 2010 Aug; 9(8):2255-64. PubMed ID: 20647339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
